drugset / Trial / NCT02276352
Relative Bioavailability of Meloxicam 2 x 7.5 mg Tablets Compared to 15 mg Tablet and Dose Proportionality Over a Dose Range of 7.5 mg and 15 mg in Healthy Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
Study to assess the relative bioavailability of two 7.5 mg meloxicam tablets (American type) compared to one 15 mg meloxicam tablet (American type), and to investigate dose-proportionality over the dosage range 7.5 mg to 15 mg
Timeline
- Start
- 1999-06
- Primary completion
- 1999-08
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Meloxicam | Small molecule | 7.5 mg | Oral |
| Subject | Meloxicam | Small molecule | 15 mg | Oral |
Indications
No indication recorded.